Cleared Traditional

K252126 - MitraPatch Mitral Valve Repair System (FDA 510(k) Clearance)

Dec 2025
Decision
150d
Days
Class 2
Risk

K252126 is an FDA 510(k) clearance for the MitraPatch Mitral Valve Repair System. This device is classified as a Nonabsorbable Expanded Polytetrafluoroethylene Surgical Suture For Chordae Tendinae Repair Or Replacement (Class II - Special Controls, product code PAW).

Submitted by Chawla Heart Technologies, LLC (Bloomfield, US). The FDA issued a Cleared decision on December 4, 2025, 150 days after receiving the submission on July 7, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.3470. To Repair Or Replace Chordae Tendinae..

Submission Details

510(k) Number K252126 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2025
Decision Date December 04, 2025
Days to Decision 150 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PAW - Nonabsorbable Expanded Polytetrafluoroethylene Surgical Suture For Chordae Tendinae Repair Or Replacement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.3470
Definition To Repair Or Replace Chordae Tendinae.